Tekla Life Profile

20.06
USD 0.08  0.4%
19.20
37%
21.52
20.00
35%
20.17

Purchase by Kent Thomas M of 1300 shares of Tekla Life

Tekla Life Sciences Investors insider trading alert for perchase of shares of beneficial interest by Kent Thomas M, the corporate stakeholder, on January 29, 2018. This event was filed by Tekla Life Sciences Inves with SEC on 2018-01-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Tekla Life Summary

Tekla Life Sciences Investors (HQL) is traded on New York Stock Exchange in USA. It is located in 2 Liberty Square and employs 13 people. The company currently falls under 'Small-Cap' category with total capitalization of 407.1 M. Tekla Life Sciences Investors has 21.17 M outstanding shares of which 76.57 K shares are currently shorted by investors with about 0.0 days to cover shorted positions. HQ LIFE SCIENCES has about 615.31 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Tekla Life Probability Of Bankruptcy

Ownership Allocation (%)

Tekla Life Sciences Risk Profiles

Key Fundamentals

Tekla Life Against Markets

Current Ratings

Tekla Life 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 51% 
Equity ratings for Tekla Life Sciences Investors are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Closed-End Fund - Equity classification in USA and traded on New York Stock Exchange exchange. more
NameTekla Life Sciences Investors
PresidentDaniel OmsteadAll Leadership
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business Address2 Liberty Square
ExchangeNew York Stock Exchange
SectorFinancial
BenchmarkDOW
Websitewww.teklacap.com/hql.html
Contact Number617 772 8500
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Reporting Now
   

Portfolio Reporting

Create custom reports across your portfolios and generate quick suggestion pitch
Hide  View All  NextLaunch Portfolio Reporting

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Management

Tekla Life Corporate Management
William Reardon Independent Trustee, CPA
Michael Bonney Independent Trustee
Oleg Pohotsky Independent Trustee, MBA
Lucinda Stebbins Independent Trustee, CPA
Uwe Reinhardt Independent Trustee, Ph.D
Rakesh Jain Independent Trustee